Impact of telephone delivered case-management on the effectiveness of collaborative care for depression and anti-depressant use:A systematic review and meta-regression by Hudson, Joanna et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Hudson, J., Coventry, P., Bower, P., Kontopantelis, E., Bee, P., Archer, J., ... Waheed, W. (Accepted/In press).
Impact of telephone delivered case-management on the effectiveness of collaborative care for depression and
anti-depressant use: A systematic review and meta-regression. PloS one.
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 09. Jul. 2020
1 
 
Impact of telephone delivered case-management on the effectiveness of collaborative 1 
care for depression and anti-depressant use: A systematic review and meta-regression 2 
Running title: Collaborative care and telephone delivered case-management   3 
 4 
Joanna L Hudson*1¶, Peter Bower2¶, Evangelos Kontopantelis2¶, Penny Bee3¶, Janine 5 
Archer4&, Rose Clarke5&, Andrew S Moriarty6¶, David A Richards7¶, Simon Gilbody6¶,Karina 6 
Lovell3&, Chris Dickens7¶, Linda Gask2&, Waquas Waheed2&, Peter A Coventry8¶ 7 
 8 
1King’s College London, Department of Psychology, Institute of Psychiatry, Psychology & 9 
Neuroscience, De Crespigny Park, London, UK 10 
 11 
2NIHR School for Primary Care Research, Centre for Primary Care and Centre for Health 12 
Informatics, Manchester Academic Health Science Centre, University of Manchester, 13 
Manchester, UK 14 
 15 
3Division of Nursing, Midwifery & Social Work, University of Manchester, Manchester, UK 16 
 17 
4School of Health and Society, University of Salford, Salford, UK 18 
 19 
5Sheffield NHS Improving Access to Psychological Therapies (IAPT), St George’s Community 20 
Health Centre, Sheffield, UK 21 
 22 
6Department of Health Sciences and Hull York Medical School, University of York, York, UK 23 
 24 
7 Institute of Health Research, University of Exeter College of Medicine and Health, 25 
University of Exeter, Exeter, UK 26 
 27 
8Department for Health Sciences and Centre for Reviews and Dissemination, University of 28 
York, York, UK 29 
 30 
*Corresponding author 31 
2 
 
Email: Joanna.Hudson@kcl.ac.uk (JLH) 32 
¶ These authors contributed equally to this work.  33 
& These authors also contributed equally to this work.34 
3 
 
Abstract 35 
Background 36 
The health service delivery framework collaborative care is an effective intervention for 37 
depression. However, uncertainties remain about how to optimise its delivery at scale. 38 
Structured case management is a core component of collaborative care; its delivery via the 39 
telephone may improve access.   40 
  41 
Aims 42 
To examine using meta-regression if telephone delivered case management diminishes the 43 
clinical effectiveness of collaborative care on depressive symptoms and anti-depressant use 44 
relative to face-to-face delivery methods.    45 
 46 
Methods 47 
Randomised controlled trials were eligible if they included collaborative care interventions 48 
for adults with depression identified using self-report measures or diagnostic interviews 49 
and reported depression outcomes. Sociodemographics, intervention characteristics, 50 
depressive symptoms, and anti-depressant use were extracted. Random effects univariable 51 
and multivariable meta-regression analyses were used to examine the moderating effect of 52 
telephone delivered case-management on outcomes.   53 
 54 
Results  55 
Ninety-four trials were identified comprising of 103 comparisons across 24, 132 56 
participants with depression outcomes and 67 comparisons from 15,367 participants with 57 
anti-depressant use outcomes. Telephone delivered case management did not diminish the 58 
effects of collaborative care on depressive symptoms (β=-0.01, 95% CI -0.12 to 0.10; 59 
p=0.86). Telephone delivered case management decreased anti-depressant medication use 60 
(relative risk 0.76, 95% CI 0.63 to 0.92; p=0.005); this effect remained when assessed 61 
simultaneously alongside other study-level moderators of collaborative care.    62 
 63 
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Conclusion   64 
Using remote platforms such as the telephone to deliver case management may be a 65 
feasible way to implement collaborative care with no loss of effectiveness on depressive 66 
symptoms. However, adherence to anti-depressant medication may decrease when 67 
telephone case management is used. 68 
 69 
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70 
Introduction 71 
Worldwide, an estimated 4.4% of the population are living with depression [1]. People with 72 
depression often do not get appropriate and timely care because health systems are not 73 
organised to deliver evidence-based treatments in an accessible format [2-4]. Collaborative 74 
care is a health service delivery framework developed to optimise depression care by using: 75 
i) multidisciplinary approaches to working with input from two or more health care 76 
professionals, ii) structured evidenced-based case management, iii) proactive and scheduled 77 
patient follow-up, and iv) enhanced inter-professional communication systems [5]. The 78 
effectiveness of collaborative care for the management of depression and anxiety in the 79 
short-term is well established [6]. However, there remains a significant translational gap 80 
between evidence of effectiveness and understanding the optimal way to implement 81 
collaborative care at scale and with reach [7]. One of the key functions of collaborative care 82 
is to enhance the way case managers can effectively work to proactively support patients to 83 
adhere to structured evidenced-based care plans. Case management may include patient 84 
contact with a health care professional to support care coordination, adherence to anti-85 
depressant medications and/or delivery of manualised psychological interventions. 86 
Traditionally, clinical contacts between health care professionals and patients occur via face-87 
to-face consultations [8]. However, alternative approaches to health care delivery via 88 
telecommunication systems (e.g. telephone, conference call, web-based interfaces) are 89 
being tested; commonly referred to as telemedicine or telepsychiatry [8, 9]. Telephone 90 
delivered care has the potential to address practical, [8, 10-12] psychological [13-16] and 91 
economic barriers to accessing care [17].  Delivering depression case management by 92 
telephone within the context of collaborative care models might offer a pragmatic approach 93 
to extend the accessibility and reach of collaborative care and support its implementation at 94 
scale. However, it is not known if using the telephone to deliver case management is 95 
associated with a diminution in effectiveness of collaborative care. We therefore undertook 96 
a systematic review with meta-regression to test if the effectiveness of collaborative care is 97 
moderated by telephone delivered case management. Meta-regression is a statistical 98 
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technique which performs a multiple regression of meta-analysed studies. It allows possible 99 
moderators of effect size heterogeneity between trials to be explored.   100 
Objectives 101 
Our primary objective was to use meta-regression analysis to explore if trials which used 102 
telephone delivered case management moderated the effectiveness of collaborative care on 103 
depressive symptoms and use of anti-depressant medications relative to trials which used 104 
face-to-face case management delivery methods.  105 
Our secondary objective was to explore whether including telephone delivered case 106 
management in a multivariable meta-regression model explains any additional variance in 107 
outcomes relative to other study-level moderators of collaborative care [6, 18, 19].  108 
Methods 109 
This systematic review and meta-regression follows the Preferred Reporting Items for 110 
Systematic Reviews and Meta-analysis Statement guidance [20] (PRISMA; See supporting 111 
information  Table A in S1 File for PRISMA checklist).  112 
Information sources 113 
We originally searched the Cochrane Collaboration Depression, Anxiety and Neurosis 114 
(CCDAN) group (now Common Mental Disorders group) trial register on 9th February 2012. 115 
The CCDAN trial register comprehensively indexed trials registered to MEDLINE, EMBASE, 116 
PsychINFO, CENTRAL, World Health Organisation’s trials portal, Clinicaltrials.gov, and 117 
CINAHL. The results of that search were published as a Cochrane Review [6].The search was 118 
updated using the CENTRAL database in December 2013 and incorporated in a previous 119 
meta-regression [19]  and meta-analysis [21]. For this review we updated this search using 120 
the CENTRAL database in October 2016 and May 2017. This is considered a sufficient and 121 
cost-effective approach for the systematic detection of randomised controlled trials of 122 
health care interventions [22]. See  Table B in S1 File for search strategy. 123 
Inclusion criteria 124 
Randomised controlled trials were included if they met these criteria:  125 
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1) Recruited adults aged 18 years or over who met criteria for a primary diagnosis of 126 
depression or who had mixed anxiety and depression. Criterion thresholds were 127 
determined using either self-report questionnaires and/or diagnostic clinical 128 
interviews.  129 
2) Used an individual or cluster randomised design, which compared collaborative care 130 
interventions in primary or community care settings with usual care or enhanced 131 
usual care.  132 
3) Tested a type of collaborative care that included these four components [5]:  133 
• Multidisciplinary appraoch, defined as two or more health care professionals, 134 
of which one must include a primary care provider (e.g. family physician 135 
and/or nurse practitioner). 136 
•  Structured evidence-based case management plan delivered by a health care 137 
professional/case manager who is not the patient’s primary care provider. 138 
Case management plans could include pharmacotherapy and/or 139 
psychotherapy.  140 
• Scheduled and proactive patient follow-up consisting of one or more planned 141 
sessions.  142 
• Enhanced inter-professional communication/support, for example: team 143 
meetings, supervision from a senior health care professional/mental health 144 
specialist.  145 
4) Measured change in depressive symptoms using self-report measures or diagnostic 146 
clinical interviews. Binary self-report depression outcomes may have included either 147 
remission or reduction in depression symptoms according to a priori defined 148 
threshold (e.g. ≥50%). 149 
Study Selection  150 
Eligible studies were identified for inclusion from our existing meta-regression of 74 151 
collaborative care randomised controlled trials for depression [19]. In addition, three 152 
authors (JH, PC, RC) screened potentially eligible studies identified from the CENTRAL search 153 
updates against the above inclusion criteria.  154 
Data extraction  155 
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Data extraction focussed on: i) characteristics of included studies, ii) characteristics of 156 
collaborative care interventions, iii) depressive symptoms and antidepressant medication 157 
use, and iv) categorical coding of study level moderators of collaborative care. 158 
Characteristics of included studies:  159 
To summarise trial characteristics the following variables were extracted: sample size, 160 
sociodemographic data, method used to diagnose depression, and baseline depression 161 
severity.  162 
Characteristics of collaborative care interventions:  163 
Consistent with Gunn et al’s [5] conceptualisation of collaborative care, we extracted the 164 
following descriptive data: i) type of health care professionals responsible for case 165 
management, ii) type of evidence-based case management plan implemented (e.g. 166 
pharmacotherapy, psychotherapy or both), iii) number of planned follow-up case-167 
management sessions (during 6 month period), and iv) methods used to enhance inter-168 
professional communication.  169 
Outcome extraction: 170 
The primary outcome was reduction in depressive symptoms. We extracted continuous or 171 
dichotomous depression outcomes for follow-up data that was closest in time to six months. 172 
If studies included two active comparator trial arms relative to the control group, we halved 173 
sample sizes to prevent double counting. The metaeff stata command [23] was used to 174 
translate dichotomous outcomes into standardised mean differences. This allowed the 175 
inclusion of both continuous and dichotomous outcomes in the same analysis.   176 
Anti-depressant use is an important process variable. Adherence to correctly prescribed 177 
medication will improve depression outcomes. We extracted antidepressant use as a 178 
dichotomous outcome and translated the data into relative risk ratios with log-179 
transformations among any studies that reported this process variable [24]. Data were 180 
extracted from studies that reported either: the proportion of patients who were using anti-181 
depressants or the proportions of patients meeting a priori defined cut-offs for appropriate 182 
levels of medication use according to self-report measures or clinical guidelines.   183 
 184 
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If trials used a cluster randomisation process, then we used standard approaches to 185 
implement the “effective sample size” procedure [25]. We used an empirically-derived 186 
intraclass correlation coefficient (ICC) of 0.02 [26].  187 
Categorical coding of case-management delivery method and study level 188 
moderators of collaborative care 189 
To examine if telephone delivered case management moderated depressive symptom 190 
outcomes and anti-depressant use a binary code (e.g. telephone versus face-to-face) was 191 
applied to each trial. We conceptualised telephone delivered case management as planned 192 
treatment sessions delivered by the case manager over the telephone. The case manager’s 193 
role may have involved supporting adherence to evidence-based pharmacotherapy and/or 194 
psychotherapy treatments. If planned case management sessions included a mix of 195 
telephone and face-to-face delivered sessions, then ≥50% of the planned case management 196 
sessions had to be delivered via the telephone for a study to be coded as telephone 197 
delivered case management intervention.  198 
 199 
In addition, the following study-level moderators were categorically coded: i) participant 200 
recruitment method (e.g. systematic screening methods using either diagnostic clinical 201 
interviews or self-report depression measures versus referral by clinicians), ii) intervention 202 
content delivered during case management sessions (e.g. pharmacotherapy only versus 203 
psychotherapy and/or pharmacotherapy), and iii) supervision frequency (e.g. scheduled 204 
supervision versus ad hoc). These three study-level moderators were selected for extraction 205 
because our previous meta-regression analysis identified them as potentially salient 206 
moderators of depression outcomes and/or anti-depressant use [19]. This approach made it 207 
possible to test if telephone delivered case management adds any additional explanatory 208 
power over and above our previously tested multivariable explanatory models of depression 209 
outcomes and anti-depressant use.  210 
 211 
Analysis 212 
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Before performing meta-regression analyses to compare the effect of collaborative care 213 
trials which delivered case management via the telephone with trials that used face-to-face 214 
case management delivery methods we first performed a meta-analysis to standardise 215 
depressive symptom and anti-depressant use outcomes. To achieve this the Stata 216 
(StataCorp LLC; Version 15 for windows) command metaan [27] was used to generate 217 
standardised mean difference effect size estimates for depressive symptoms (meta-analysis 218 
model one) and relative risk effect size estimates for anti-depressant use outcomes (meta-219 
analysis model two). In both cases, a DerSimonian-Laird [28] random-effects inverse 220 
variance model was used to better account for heterogeneity. The I² estimate was used to 221 
estimate the degree of heterogeneity across included studies; it provides a percentage 222 
estimate of between study variability [29]. We also report the 95% confidence intervals for 223 
I2.. 224 
Four meta-regression analyses were then performed usingthe metareg [30] command. 225 
Univariable meta-regression analyses were performed to test our primary objective. We 226 
examined if telephone delivered case management moderated the effect of collaborative 227 
care on depressive symptoms (univariable meta-regression model one) and anti-depressant 228 
use (univariable meta-regression model two). The metareg command was also used to test 229 
our secondary objective. Using multivariable meta-regression analyses, we examined if 230 
telephone delivered case management added explanatory effects on outcomes relative to 231 
our previously tested study-level moderators of collaborative care outcomes [19]. We 232 
simultaneously entered the following study-level explanatory variables into a meta-233 
regression model with depressive symptoms as the outcome variable: telephone delivered 234 
case management, recruitment method, intervention content, and supervision frequency 235 
(multivariable meta-regression model three). These three variables were selected for 236 
inclusion in the model to replicate our previously tested study-level moderators [19]. 237 
Likewise, when anti-depressant use was the outcome variable we simultaneously entered: 238 
telephone delivered case management alongside recruitment method (multivariable meta-239 
regression model four). Recruitment method was identified for inclusion in the model to 240 
replicate our previous multivariable study-level meta-regression findings for anti-depressant 241 
use [19].  242 
Risk of bias 243 
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Study sample size was used as a proxy indicator for publication bias by exploring the 244 
relationship between study effect size and sample size [31]. We quantified the effect of risk 245 
of within study bias associated with allocation concealment which was coded as a binary 246 
variable [32]. 247 
Results 248 
Characteristics of included studies 249 
Ninety-four trials were identified that included 103 comparisons from 24, 132 participants 250 
with depression outcomes and 66 comparisons from 15, 367 participants with anti-251 
depressant use outcomes; see Fig 1 for PRISMA flow diagram. This represents a 27% 252 
increase on the number of trials included in our previous systematic review with meta-253 
regression [19]. Collaborative care case management was delivered using the telephone in 254 
42% (n=43) of the included trial comparisons. Across the 103 comparisons, 53 comparator 255 
groups used a mental health care professional to deliver their case management. Most of 256 
the intervention comparators opted for scheduled supervision (62%). A summary of the 257 
collaborative care characteristics for each trial is provided in  Table C S1 File. A third of the 258 
comparator trials were conducted in the US, whilst only 3% (n=3) were conducted in low 259 
and middle-income countries. Characteristics of included studies are described in  Table D 260 
S1 File. A reference list of all included studies is available in Reference List AS1 File.  261 
Fig 1. PRISMA Flow Diagram 262 
[INSERT FIG 1 HERE] 263 
Meta-analysis model one: Depressive symptoms 264 
Meta-analysis findings showed that collaborative care was associated with greater 265 
improvements in depressive symptoms when compared with usual care (standardised mean 266 
difference, SMD −0.30, 95% CI −0.36 to −0.25; p<0.001; I2 = 73.1%, 95% CI 67.7% to 78.0%, 267 
k=103).  268 
Meta-analysis model two: Anti-depressant use 269 
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Meta-analysis findings showed that collaborative care was associated with greater use of 270 
anti-depressant medications when compared with usual care (relative risk, RR 1.48, 95% CI 271 
1.37 to 1.59; p<0.001; I2 = 80.1%, 95% CI 75.2% to 84.1%, k=66).  272 
Univariable meta-regression model one: The moderating effect of telephone 273 
delivered case management on depressive symptoms 274 
Univariable meta-regression analyses showed that telephone delivered case management 275 
did not have a statistically significant moderating effect on depression outcomes (study level 276 
β=-0.01, 95% CI -0.12 to 0.10; p=0.86; I2 = 73.7%, k=101). Comparable depressive symptom 277 
effect size estimates were observed for trials which used telephone case management 278 
delivery methods relative to face-to-face delivery as are summarised in Fig. 2.  279 
Fig 2: Effects of collaborative care on depression outcomes for studies that used telephone 280 
delivered case management versus face-to-face delivered case management. Intervention 281 
= Collaborative care; Control = Usual care or enhanced usual care 282 
[FIG 2 TO BE INSERTED HERE] 283 
Univariable meta-regression model two: The moderating effect of telephone 284 
delivered case management on anti-depressant use 285 
Univariable meta-regression analyses showed that telephone delivered case management 286 
had a statistically significant moderating effect on anti-depressant use (RR=0.76, 95% CI 0.63 287 
to 0.92; p=0.005; I2 = 79.6%, k=66). Studies that delivered case management via the 288 
telephone reported lower use of anti-depressant medications. Fig 3 summarises the effect 289 
size differences for anti-depressant use across telephone delivered case management 290 
studies versus studies that used face-to-face delivered case management. 291 
Fig 3: Effects of collaborative care on anti-depressant use for studies that used telephone 292 
delivered case management versus face-to-face delivered case management. Intervention 293 
= Collaborative care; Control = Usual care or enhanced usual care 294 
[FIG 3 TO BE INSERTED HERE] 295 
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Multivariable meta-regression model three: Testing telephone delivered case 296 
management relative to other moderators of depressive symptoms in 297 
collaborative care trials 298 
Multivariable meta-regression analyses showed that telephone delivered case management 299 
did not have a statistically significant explanatory effect on depressive symptoms when 300 
entered simultaneously alongside the following explanatory variables: study recruitment 301 
method, intervention content, and supervision frequency.  Only scheduled supervision 302 
frequency (relative to ad hoc supervision frequency; study level ß=-0.16, 95% CI -0.27 to -303 
0.04, p=0.008, k=101) had a statistically significant effect on depressive symptoms. Studies 304 
that had regular scheduled supervision reported greater improvements in depression 305 
outcomes relative to studies which used ad-hoc supervision structures.  Table 1 summarises 306 
the findings of multivariable meta-regression model three. 307 
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Table 1:  Multivariable meta-regression model three – outcome depressive symptoms  308 
Explanatory Variables  Regression Coefficient 
(95% CI) 
SE P  
Case management delivery method Telephone (vs face-to-face)  0.02 (-0.09 to 0.14)   .06 .681 
Recruitment method Systematic (vs GP referral)  -0.11 (-0.25 to 0.03)  .06 .106 
Intervention content Psychotherapy or both (vs medication only)  -0.04 (-0.16 to 0.07) .06 .451 
Supervision frequency  Scheduled (vs ad hoc) -0.16 (-0.27 to -0.04) .06 .008 
 Not applicable (vs ad hoc)  0.07 (-0.21 to 0.34) .14 .579 
101 comparisons, I²=67.93 309 
 310 
Key: CI – Confidence interval 311 
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Multivariable meta-regression model four: Testing telephone delivered case 312 
management relative to other moderators of anti-depressant use in 313 
collaborative care trials 314 
Multivariable meta-regression analyses showed that case management delivery method  315 
remained as a statistically significant explanatory variable when entered simultaneously 316 
alongside study recruitment method. Trials which used telephone-delivered case 317 
management relative to face-to-face case management were statistically less likely to use 318 
anti-depressant medication (study level RR=0.76, 95% CI 0.64 to 0.91, p=0.002, k=66). 319 
Likewise, recruitment into the trial using systematic methods of identification relative to 320 
opportunistic identification of depression improved anti-depressant medication use (study 321 
level RR=1.45, 95% CI 1.16 to 1.80, p=0.001, k=66). Table 2 summarises the findings from 322 
the multivariable meta-regression model four.323 
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Table 2: Multivariable meta-regression model four – outcome anti-depressant medication use 324 
 325 
Explanatory Variables  Relative risk (95% CI) SE P  
Telephone support Telephone (vs Face-to-face)  0.76 (0.64 to 0.91) .07 .002 
Recruitment method Systematic (vs GP referral)  1.45 (1.16 to 1.80)  .16 .001 
66 comparisons, I²=77.1  326 
 327 
Key: CI = Confidence interval328 
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Publication bias 329 
We statistically tested for publication bias by exploring the relationship between effect size 330 
and sample size. These findings were statistically non-significant for depressive symptoms 331 
and anti-depressant use. These outcomes reduce the likelihood that our findings are 332 
vulnerable to publication bias. 333 
Risk of within study bias 334 
There was no statistically significant effect of allocation concealment on depressive 335 
symptoms or anti-depressant use, decreasing the likelihood that our findings are impacted 336 
upon by trial quality.   337 
Discussion  338 
We conducted a meta-regression analysis to examine whether trials that used telephone 339 
delivered case management methods diminished the effect of collaborative care on 340 
depressive symptoms relative to collaborative care trials that tested face-to-face case 341 
management delivery methods. We found no evidence to support this, therefore suggesting 342 
that telephone and face-to-face delivered case management delivery methods have 343 
equivalent effects on depressive symptoms when implemented as part of a collaborative 344 
care intervention. Consistent with our previous meta-regression [19], use of scheduled and 345 
regular supervision from a senior clinician were the only study-level moderators which 346 
bolstered the effects of collaborative care on depressive symptoms. Processes of care, 347 
specifically use of anti-depressant medication, were improved in trials that used face-to-face 348 
delivered case management relative to telephone delivered case management. Case-349 
management delivery method remained a statistically significant explanatory variable when 350 
entered simultaneously alongside other hypothesised study-level moderators of anti-351 
depressant use in collaborative care contexts. It is important to highlight that these findings 352 
are based on meta-regression observational analyses only and the implications of this are 353 
discussed below. 354 
Strengths and Limitations 355 
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This is the first systematic review with meta-regression to assess the impact of telephone 356 
delivered case management as part of a collaborative care intervention on depressive 357 
symptoms and processes of care. In addressing this novel research question we also 358 
updated the findings of a previous Cochrane review [6]. This provided an opportunity to 359 
replicate previous multivariable meta-regression analyses using a dataset that included 21 360 
more trials [19].  Using this enlarged dataset increased statistical power [33] and improved 361 
the reliability of our effect size estimates which rely on asymptomatic sampling methods 362 
[34]. However, large amounts of statistical heterogeneity remain unexplained in both 363 
multivariable meta-regression models. The capability of meta-regression analyses to explain 364 
the impact of clinical and methodological heterogeneity on trial outcomes is reliant on the 365 
comprehensive reporting of these characteristics. CONSORT guidelines have improved 366 
methodological reporting and assessment of trial quality [35]. Indeed, we explored the 367 
effect of trial quality using allocation concealment as a hypothesised moderator of outcome. 368 
However, the reporting of intervention characteristics, specifically their “active ingredients” 369 
and planned vs actual processes of intervention delivery (e.g. number and intensity of 370 
treatment sessions), remain poorly reported. The template for intervention description and 371 
replication (TIDieR) checklist provides a framework for reliably reporting this information 372 
[36]. Using TIDieR within trial reports will enhance the capabilities of future meta-regression 373 
analyses to explore these factors with precision and statistical power. In addition, trials that 374 
seek to elaborate on how collaborative care is implemented need to go a step further and 375 
consider the potential mechanisms of action through which intervention effects are 376 
produced [37-39]. This will allow intervention developers to identify what aspects of their 377 
evidenced-based treatment protocols can remain the same (e.g. when mechanisms of 378 
action respond to clinical intervention as hypothesised) versus which aspects of the 379 
treatment protocols need updating when hypothesised mechanisms of change do not 380 
respond to clinical intervention method(s) used. However, our systematic review with meta-381 
regression found that only two thirds of the included studies measured change in anti-382 
depressant medication use which is an important process variable. Improved reporting of  383 
patient characteristics and treatment components as well as measuring hypothesised 384 
mechanisms of change, will more likely lead to a better understanding of how to maximise 385 
the benefits of collaborative care and tailor delivery to meet the needs of patients [39].   386 
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Nonetheless, meta-regression remains reliant on aggregate level data extracted from across 387 
trials. Observed relationships between identified study-level moderators may be 388 
confounded by individual patient-level characteristics (e.g. gender, patient preference for 389 
telephone case management) or indeed other between-trial characteristics (e.g. city versus 390 
rural settings) [40]. The potential for between-trial confounding was offset by our use of 391 
multivariable meta-regression analyses, but unmeasured confounding at the individual and 392 
study level may still  have occurred [41]. To truly establish the impact of telephone delivered 393 
case management on outcomes comparative effectiveness randomised controlled trials of 394 
collaborative care which directly compare telephone with face-to-face delivery methods are 395 
needed. We are aware of only one such depression trial to date which was previously not 396 
included in our effectiveness reviews because the comparator was not usual care [42].  The  397 
study found that telephone case management had larger effects on depression outcomes 398 
when compared with face-to-face delivery methods when offered in a rural setting in the 399 
US.  400 
Interpretation of findings and implications for research, practice, 401 
and policy 402 
The UK Five Year Forward View for Mental Health emphasises the need to drive and scale 403 
improvements in mental health services with priorities focused on access, quality and 404 
integrated care [43]. Within this policy context there is scope to prioritise the 405 
implementation of services that overcome practical and psychological barriers to accessing 406 
depression treatments [10-16]. Telephone delivered cognitive-behavioural therapy (CBT) is 407 
associated with equivalent improvements in depression outcomes and lower attrition when 408 
compared with face-to-face delivery methods, but possibly at the expense of maintaining 409 
gains in depression outcomes when treatment ends [44]. Therefore, telephone delivered 410 
case management, implemented as part of a collaborative care framework, may improve 411 
depression outcomes for up to six months and possibly beyond [45] whilst retaining 412 
equivalent effects as face-to-face case management. In this sense, telephone delivered case 413 
management, as part of collaborative care, is a promising intervention to translate into 414 
practice the goals of the Five Year Forward View [43] by providing a platform to implement 415 
high quality mental health care at scale and with reach.  416 
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When used as part of collaborative care, telephone delivered case management is an 417 
acceptable and feasible way to increase access to mental health care among hard to reach 418 
communities, including low income and ethnic minority groups who live in high income 419 
countries [46]. This may partly owe to the fact that telephone contacts can reduce stigma 420 
associated with attendance with mental health clinics [47]. Additionally, telemedicine offers 421 
greater choice to people who prioritise access and availability of services over the co-422 
location of practitioner and patient [14]. The telephone is the most ubiquitous 423 
communication technology. Advances in connectivity and smart phone technology have led 424 
to the rapid spread of mobile phone use. Globally the number of mobile technology users is 425 
expected to surpass 5 billion by 2019 with over 70% of users concentrated in low and 426 
middle income countries (LMIC) [48]. In LMIC countries geographic barriers to accessing 427 
mental health care might prevail making telephone delivered case management the optimal 428 
way to deliver structured care plans as part of collaborative care.  429 
However, prioritising the implementation of collaborative care on the grounds of access and 430 
reach should not compromise patient centred care that meets patients’ expectations and 431 
preferences. The relationship between patient and practitioner (the therapeutic alliance) is 432 
an important mechanism for improving outcomes in psychological therapy [49]. For some 433 
patients, telephone case management as part of collaborative care may be perceived as too 434 
impersonal and anonymous, possibly reducing opportunities for generating a therapeutic 435 
alliance [50]. However, studies that have quantitatively assessed this variable report no 436 
significant differences in patients’ ratings of alliance between telephone and face-to-face 437 
interventions [51, 52].  There is then scope to better understand and model which patients 438 
might prefer or benefit from telephone case management using rich datasets collected as 439 
part of individual patient data meta-analyses of the effectiveness of collaborative care [53]. 440 
In addition, understanding how to optimise the delivery of telephone delivered case 441 
management by considering, for example, dose-response relationships using the latest 442 
statistical modelling techniques is needed [54]. However, to robustly study these factors 443 
they must be appropriately considered at the trial design phase [39]. 444 
The observation that mode of delivery does not impact on depression outcomes but does 445 
reduce adherence to anti-depressant medication is notable. Limited research in non-mental 446 
healthcare settings suggests that patients may possess clear beliefs about how they value 447 
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the role of communication technologies in their care [55]. While telemedicine is perceived 448 
as appropriate for routine consultations, richer face-to-face exchanges have traditionally 449 
been associated with the receipt of more complex treatments. Thus, users of health services 450 
are likely to hold a variety of beliefs regarding remotely-delivered interventions depending 451 
upon the context in which their interactions occur.  When telephone interventions are 452 
delivered as part of a collaborative care it is possible that they are predominantly seen by 453 
patients and providers as a means to coordinate care and/or deliver psychological therapies 454 
rather than monitor medication use and adherence. However, this proposition needs to be 455 
empirically validated using qualitative methods to generate greater understanding about 456 
patient and provider beliefs about the merit and value of using the telephone as part of 457 
collaborative care. To achieve these aims, exploring patients’ perceived acceptability and 458 
utility of treatment interventions and their mode of delivery may help clinicians identify 459 
potential barriers to uptake and treatment fidelity and address these directly. Theoretical 460 
frameworks on acceptability and utility of treatment interventions may help to guide 461 
clinicians’ lines of Socratic questioning [56]. 462 
Conclusion 463 
This meta-regression analysis suggests that the use of the telephone to deliver case 464 
management does not reduce the effectiveness of collaborative care on depression 465 
outcomes. The results for depression outcomes were no different in trials of collaborative 466 
care that used telephone case management than trials that used face-to-face case 467 
management. However, trials that used telephone delivered case-management reported 468 
reduced adherence to anti-depressant medication highlighting the need to consider how the 469 
mode of delivery may shape patient and health care professionals understanding about the 470 
purpose of the case management. Embedding telemedicine within collaborative care 471 
frameworks has the potential to improve access and reach of high quality mental health 472 
care globally.  473 
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